TLR7 and cardiac hypertrophy: The induction of cardiac hypertrophy by the serum or splenocytes from R848-treated TC mice suggested that the cardiovascular pathology in R848-treated TC mice may result at least in part from their enhanced immune response to TLR7 activation.